Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mitra Investindo Tbk. (MITI) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Mitra Investindo Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Mitra Investindo Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Mitra Investindo Tbk. trades at Rp286 (market cap 862.62B, 78.12M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,730 (market cap 12.36T, 1.41M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 14.3× Mitra Investindo Tbk.'s market cap, and Mitra Investindo Tbk. is more actively traded (78.12M versus 1.41M). Which is the better fit depends on your goals.

MITITSPC
Market Cap
862.62B12.36T
Volume
78.12M1.41M
Lot
781.23K14.08K
Turnover
21.33B3.83B
Average Price
272.982,722.04
Value
21.33B3.83B
Indicative Equilibrium Price
2862,730
Indicative Equilibrium Volume
5312.51K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MITI
View details
TSPC
View details

About Mitra Investindo Tbk.

PT Mitra Investindo Tbk (the Company) was established based on notarial deed No. 280 dated 16 September 1993 of Misahardi Wilamarta, S.H., notary in Jakarta, under the name of PT Minsuco International Finance. The Company's Articles of Association was amended several times, which one of the amendments was based on notarial deed No. 10 dated 15 March 2006 of Amrul Partomuan Pohan, S.H., llm., Notary in Jakarta, concerning the merger of PT Siwani Trinitra Tbk with PT Caraka Berkat Sarana to become PT Mitra Investindo Tbk.

Read more on MITI

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC